Insider Trading & Ownership - Votruba Michal

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Votruba Michal

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-10
Other
2024-06-11
7:02 pm
N/A
2034-06-10
BioXcel Therapeutics Inc.BTAIVotruba Michal
Director
17,000$017,000
(Direct)
View
2024-06-10
Option Award
2024-06-11
7:02 pm
N/A
2034-06-10
BioXcel Therapeutics Inc.BTAIVotruba Michal
Director
17,000$017,000
(Direct)
View
2023-06-26
Other
2023-06-28
4:56 pm
N/A
2033-06-26
BioXcel Therapeutics Inc.BTAIVotruba Michal
Director
17,000$017,000
(Direct)
View
2023-06-26
Option Award
2023-06-28
4:56 pm
N/A
2033-06-26
BioXcel Therapeutics Inc.BTAIVotruba Michal
Director
17,000$017,000
(Direct)
View
2022-05-19
Other
2022-05-23
6:48 pm
N/A
2032-05-19
BioXcel Therapeutics Inc.BTAIVotruba Michal
Director
17,000$017,000
(Direct)
View
2022-05-19
Option Award
2022-05-23
6:48 pm
N/A
2032-05-19
BioXcel Therapeutics Inc.BTAIVotruba Michal
Director
17,000$017,000
(Direct)
View
2021-06-11
Other
2021-06-15
5:36 pm
N/A
2031-06-11
BioXcel Therapeutics Inc.BTAIVotruba Michal
Director
14,500$014,500
(Direct)
View
2021-06-11
Option Award
2021-06-15
5:36 pm
N/A
2031-06-11
BioXcel Therapeutics Inc.BTAIVotruba Michal
Director
14,500$014,500
(Direct)
View
2020-05-21
Other
2020-05-26
4:17 pm
N/A
2030-05-21
BioXcel Therapeutics Inc.BTAIVotruba Michal
Director
20,000$020,000
(Direct)
View
2020-05-21
Option Award
2020-05-26
4:17 pm
N/A
2030-05-21
BioXcel Therapeutics Inc.BTAIVotruba Michal
Director
20,000$020,000
(Direct)
View